![]() |
市場調査レポート
商品コード
1541458
避妊具市場レポート:器具タイプ、エンドユーザー、流通チャネル、地域別、2024~2032年Contraceptive Devices Market Report by Device Type, End User, Distribution Channel, and Region 2024-2032 |
||||||
カスタマイズ可能
|
避妊具市場レポート:器具タイプ、エンドユーザー、流通チャネル、地域別、2024~2032年 |
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 145 Pages
納期: 2~3営業日
|
世界の避妊具市場規模は2023年に143億米ドルに達しました。今後、IMARC Groupは、市場は2032年までに226億米ドルに達し、2024~2032年の間に5.1%の成長率(CAGR)を示すと予測しています。家族計画の重要性に対する意識の高まり、意図しない妊娠の発生率の増加、家族計画プログラムを推進するための政府の取り組みや資金の増加が、市場を牽引する主要要因のいくつかです。
避妊具は、個人やカップルが意図しない妊娠を防ぐのに不可欠なツールです。これらの器具は、受精プロセスを阻害することで妊娠を効果的に防止します。避妊具は、そタイプによってさまざまな材料や技術を用いて作られています。コンドームやダイアフラムなどのバリア法は、精子が卵子に到達するのを防ぐもので、一般的にラテックスやポリウレタン(PU)などで作られています。避妊ピル、注射、パッチなどのホルモン避妊薬には、女性の月経周期を調節し、排卵を防ぐ合成ホルモンが含まれています。一方、子宮内避妊具(IUD)は銅製かプラスチック製で、子宮に挿入して妊娠を防ぎます。避妊具には、家族計画を立てたり、生殖に関する健康について十分な情報を得た上で選択したりする自主性を個人に与えるなど、多くの利点があります。男性にも女性にも使用でき、避妊のための幅広い選択肢を記載しています。正しく使用すれば一般的に安全で効果的であり、多くの器具は性感染症(STI)の予防や月経出血の減少など、その他の特典も記載しています。
世界の避妊具市場は、家族計画法に対する認識と採用の増加、意図しない妊娠の発生率の増加など、いくつかの要因によって牽引されています。さらに、家族計画プログラムを推進するための政府の取り組みや資金の増加、STIの急増が市場の成長を後押ししています。さらに、経口避妊薬、子宮内避妊具、コンドーム、皮下インプラントなど、さまざまな避妊具が入手可能であること、消費者の支出力が高まっていることも、市場成長を後押ししています。これとは別に、長時間作用型可逆避妊薬の市場開拓、eコマースセグメントの拡大、製品イノベーションの拡大動向などが市場成長を促進しています。これに伴い、非ホルモン性避妊薬や天然避妊薬に対する需要の増加や、女性がコントロールできる避妊法の受け入れが急増していることも市場成長に寄与しています。その他、メーカーと医療プロバイダーとの提携や協力関係の増加、新興市場における流通網の拡大などが、市場の成長をさらに促進すると予想されます。
The global contraceptive devices market size reached US$ 14.3 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 22.6 Billion by 2032, exhibiting a growth rate (CAGR) of 5.1% during 2024-2032. The increasing awareness about the importance of family planning, the growing incidence of unintended pregnancies, and the rising government initiatives and funding to promote family planning programs represent some of the key factors driving the market.
Contraceptive devices are essential tools that help individuals and couples prevent unintended pregnancies. These devices effectively prevent pregnancy by inhibiting the fertilization process. They are made using various materials and technologies, depending on the type of device. Barrier methods, such as condoms and diaphragms, prevent sperm from reaching the egg and are typically made of latex, polyurethane (PU), or other materials. Hormonal contraceptives, such as birth control pills, injections, and patches contain synthetic hormones that regulate the woman's menstrual cycle and prevent ovulation. On the other hand, intrauterine devices (IUDs) are made of either copper or plastic and are inserted into the uterus to prevent pregnancy. Contraceptive devices offer numerous advantages, such as providing individuals with the autonomy to plan their families and make informed choices about their reproductive health. They can be used by both men and women, offering a wide range of options for contraception. They are generally safe and effective when used correctly, and many devices also provide additional benefits, such as protection against sexually transmitted infections (STIs) or reduced menstrual bleeding.
The global contraceptive devices market is driven by several factors, including the increasing awareness and adoption of family planning methods and the growing incidence of unintended pregnancies. Moreover, the rising government initiatives and funding to promote family planning programs and the surging prevalence of STIs are boosting the market growth. Furthermore, the availability of various contraceptive devices, including oral contraceptives, intrauterine devices, condoms, and subdermal implants, and inflating consumer expenditure power are driving the market growth. Apart from this, the development of long-acting reversible contraceptives, the expansion of the e-commerce sector, and the inflating trend of product innovations are fueling the market growth. In line with this, the increasing demand for non-hormonal and natural contraceptives and the surging acceptance of female-controlled contraceptive methods are also contributing to the market growth. Other factors, such as the growing number of partnerships and collaborations between manufacturers and healthcare providers, as well as the expansion of distribution networks in emerging markets, are expected to propel the market growth further.
IMARC Group provides an analysis of the key trends in each sub-segment of the global contraceptive devices market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on device type, end user and distribution channel.
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUDs
Others
The report has provided a detailed breakup and analysis of the contraceptive devices market based on the device type. This includes condoms, diaphragms, cervical caps, sponges, vaginal rings, IUDs, and others. According to the report, condoms accounted for the largest market share.
Male
Female
A detailed breakup and analysis of the contraceptive devices market based on the end user has also been provided in the report. This includes male and female. According to the report, males accounted for the largest market share.
Hospital Pharmacies
Retail Pharmacies
Online Stores
Others
A detailed breakup and analysis of the contraceptive devices market based on the distribution channel has also been provided in the report. This includes hospital pharmacies, retail pharmacies, online stores, and others. According to the report, retail pharmacies accounted for the largest market share.
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for contraceptive devices. Some of the factors driving the North America contraceptive devices market included increasing awareness and acceptance, technological advancements, government initiatives, and rising prevalence of STIs.
The report has also provided a comprehensive analysis of the competitive landscape in the global contraceptive devices market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Allergan plc, Bayer AG, Church & Dwight Co., Inc., CooperSurgical Inc., Merck & Co., Mylan Inc., Pfizer Inc., Reckitt Benckiser Group plc, Teva Pharmaceutical Industries Ltd., and The Female Health Company. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.